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Children with epilepsy are a source of huge concern to their parents irrespective of their educational status. They have fears, notions, misconceptions, and varying level 
of commitments to handle the special child. The role of medical 
personnel handling the family is extremely crucial. The health-
care providers be it doctors, nurses or paramedical staff coming 
in their contact adds to their information and belief in ways more 
than one. Among the various factors affecting antiepileptic drug 
usage, the major determinants are age and gender of patients, 
side effect profile and availability of drugs, finances of patients, 
and behavior and influence of the treating physician [1]. For 
individuals with epilepsy, adherence to medication is crucial in 
preventing or minimizing seizures and their cumulative impact 
on everyday life. As many as 30-50% of persons with epilepsy 
are noncomplaint in following the treatment and more than half of 
epilepsy patients have poor seizure control due to non-adherence 
to medication [2]. This study aims at finding the various causes 
which affect drug compliance in these children.
METHODS
The study was conducted in tertiary care children hospital 
of North India. The questionnaire-based study proposal was 
ethically cleared by hospital’s Ethical Committee. The patients 
were informed before the interview about their inclusion in this 
study, and their consent was taken for the same. A total of 100 
children with epilepsy and their parents were interviewed during 
the study period. All children aged 1-12 years with diagnosis of 
epilepsy (irrespective of any medical cause), on drug therapy for 
at least 3 months were included in the study.
No drug intervention, diet modification or any blood sampling 
was done. The study was stopped where it was inconvenient and 
interfering with the routine care of the patient. The questionnaire 
included sex and age of child, duration of disease, treatment 
regimen, age and educational level of parents, information 
on compliance for medication taken, and the reason for 
noncompliance. Drug compliance was considered as satisfactory 
if the patient took the medication in correct dosage, regularly 
and as planned for him/her based on their yes/no response to the 
questions about the above-mentioned items. The data was entered 
in MS excel, descriptive statistical analysis was performed using 
appropriate formulas and Student t-test was used for calculating 
p value (p<0.5 was considered significant).
RESULTS
A total 100 children with epilepsy (63 males and 37 females) 
and their parents were interviewed. 52% of these children 
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were in the age group of 1-4 years. The age of onset of seizure 
was  <1 year in 52% of the cases. Valproate monotherapy was 
given to 83% cases, and combination therapy (Table 1) was 
given to 17% cases. The patients came mostly from parts of 
North India including 63% from Delhi, 22% from Uttar Pradesh, 
8% from Haryana, and 7% from others states. Parents of 37% 
children were at least 10th pass. Basic or no formal education 
was received by 63% parents. Only 10% were graduates. Family 
history of an affected parent in 5% cases, affected sibling in 4% 
and of a neurological disorder in anyone in the family in 56% 
cases was observed. More than one seizure episode per day was 
seen in 48% of the children (Table 2).
Out of total patients, 29% were non-compliant. No significant 
association of noncompliance was found with etiology of epilepsy, 
monotherapy versus polytherapy, and duration of disease, 
mother’s age and parental education (p>0.05). Costly medication 
and unavailability in drug stores was reported by 24.1% of 
non-compliant patients. The study also found that 41.3% of 
noncompliant patients suffered from higher seizures frequency 
due to lack of timely medication. Misconceptions and lack of 
effective communication with doctor were reported by 82.7% of 
noncompliant parents. The common misconceptions were that 
antiepileptic drugs when taken for the long term may result in 
harmful side effects. Many also believed that it is correct to stop 
the drug therapy on their own once the sign and symptoms settle 
down. Some also found it embarrassing to administer drugs to the 
child in front of others.
DISCUSSION
Compliance is the extent to which a person’s behavior 
coincides with medical or health advices [3]. The reasons for 
non-compliance may include discomfort resulting from treatment, 
expense of treatment, decisions based on personal judgments 
about the effectiveness of the proposed treatment, maladaptive 
coping styles (e.g., denial of illness), or mental disorders [4]. 
Several methods are used to measure therapeutic adherence. 
Indirect methods like self-reports and interviews with the patient 
are simplest and most common method for measuring medication 
adherence [5]. Questionnaire-based studies usually overestimates 
compliance [6].
The compliance studies in adult patients with epilepsy show 
good compliance because a neglect of medical treatment may 
cause epileptic seizures. Studies in adolescents with epilepsy 
showed poor compliance [7]. In children, compliance studies 
have given varying result; 72.4% in children attending Motahary 
Clinic of Shiraz [8], 42% in Cincinnati Children’s Hospital [9], 
86% in Pediatric University Hospital in Riyadh [10]. Despite 
our recent economic progress, a wide treatment gap is very 
much a reality and a big challenge for health care provider. 
This has been reported as high as 78% and 71% in Indian 
studies [11,12].
A study showed that compliance improved when patient was 
satisfied with the consultation process and was asked to recall 
the information [13]. Multiple visits to doctor enhanced the 
communication and thus compliance. Studies have also found 
that adherence to medication is good when health care provider 
are emotionally supportive, giving reassurance and respect to the 
patient and regularly interact with the patient to discuss how to 
live with the disease [14].
Caring for a child with epilepsy involves facing multiple 
challenges simultaneously. A majority of these children will 
have associated learning and behavior disorders leading to 
significant difficulties at school [15]. In this study, 48 (20.8%) 
school going children were irregular in school, 18% were 
weak in studies, and 41.6% were not socially interactive 
with their peers. Around 43.7% parents stated that they are 
unable to send their children to school due to high seizures 
frequency. Our study has limitations due to small sample size 
as this study was a part of ICMR-STS project in which data 
collection had to complete in a period of 2-month. Therefore, 
a larger study would be more useful to assess the causation of 
non-compliance.
CONCLUSION
Assessment of adherence should be part of routine management 
of epilepsy. Noncompliance in the present study was 29%. As 
the noncompliance is not significantly associated with any usual 
causative factor, improvement in compliance by paying attention 
to psychological health of the child, group education, medication 
education for parents, especially through written information, 
and support from other affected parents and physicians maybe 
important and useful. Awareness campaigns in general public 
about epilepsy should be done frequently to reduce the associated 
taboo.
Table 1: The various drug combinations used in children (n=17) 
with epilepsy
Drugs are given for treatment Number of patients
Valproate+topiramate 1
Epitoin+valproate 4
Valproate+clobazam 6
Valproate+levetiracetam 2
Epitoin+clobazam+carbamazepine 1
Valproate+clobazam+topiramate 1
Valproate+levetiracetam+epitoin 1
Phenobarbital+levetiracetam+phenytoin 1
Total 17
Table 2: Frequency of seizure episodes in the patients (n=100)
Frequency Number of cases
Only 1-2 episodes till date 2
One in 1 year gap 7
One in>1 month gap 28
One in>1 week gap 15
More than one episode daily 48
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